Use of olanzapine in anorexia nervosa.
Menaster
Michael
M
D000856:Anorexia Nervosa / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005473:Fluoxetine / Q000627:therapeutic use; D006801:Humans; D000077152:Olanzapine; D010555:Personality Inventory; D012107:Research Design / Q000592:standards; D018401:Sample Size; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D016896:Treatment Outcome; D015430:Weight Gain
D014150:Antipsychotic Agents; D001569:Benzodiazepines; D005473:Fluoxetine; D000077152:Olanzapine; D017367:Selective Serotonin Reuptake Inhibitors